CoreFirst Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Buy |
7,267
+610
| +9% | +$28.2K | 0.19% | 91 |
|
|
2025
Q1 | $406K | Hold |
6,657
| – | – | 0.26% | 79 |
|
|
2024
Q4 | $377K | Sell |
6,657
-173
| -3% | -$9.79K | 0.22% | 83 |
|
|
2024
Q3 | $353K | Sell |
6,830
-5,110
| -43% | -$264K | 0.2% | 94 |
|
|
2024
Q2 | $496K | Sell |
11,940
-440
| -4% | -$18.3K | 0.33% | 71 |
|
|
2024
Q1 | $671K | Hold |
12,380
| – | – | 0.42% | 57 |
|
|
2023
Q4 | $635K | Sell |
12,380
-627
| -5% | -$32.2K | 0.42% | 60 |
|
|
2023
Q3 | $755K | Sell |
13,007
-585
| -4% | -$34K | 0.54% | 46 |
|
|
2023
Q2 | $869K | Sell |
13,592
-225
| -2% | -$14.4K | 0.61% | 38 |
|
|
2023
Q1 | $958K | Sell |
13,817
-900
| -6% | -$62.4K | 0.7% | 36 |
|
|
2022
Q4 | $1.06M | Buy |
14,717
+800
| +6% | +$57.6K | 0.8% | 26 |
|
|
2022
Q3 | $989K | Sell |
13,917
-2
| -0% | -$142 | 0.85% | 26 |
|
|
2022
Q2 | $1.07M | Buy |
13,919
+2,000
| +17% | +$154K | 0.85% | 26 |
|
|
2022
Q1 | $871K | Hold |
11,919
| – | – | 0.6% | 43 |
|
|
2021
Q4 | $743K | Sell |
11,919
-240
| -2% | -$15K | 0.48% | 50 |
|
|
2021
Q3 | $720K | Sell |
12,159
-1,807
| -13% | -$107K | 0.5% | 46 |
|
|
2021
Q2 | $933K | Buy |
13,966
+87
| +0.6% | +$5.81K | 0.64% | 40 |
|
|
2021
Q1 | $876K | Sell |
13,879
-400
| -3% | -$25.2K | 0.6% | 41 |
|
|
2020
Q4 | $886K | Buy |
+14,279
| New | +$886K | 0.66% | 35 |
|